Skip to main content
SpringerLink
Log in

Maple syrup urine disease: Interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination

  • Published:
Journal of Inherited Metabolic Disease

Summary

Four patients with classical maple syrup urine disease were treated for up to 5885 days per patient with a relaxed protocol allowing branched-chain amino acid levels in plasma to rise about 5 times the normal mean value. The patients have had satisfactory development and lifestyle. They spent 318 days in hospital during 19 937 aggregate treatment days. Plasma levels of leucine and the corresponding 2-oxo acid were shown to be elevated disproportionately relative to the other branched-chain metabolites. Levels of isoleucine and valine were lower than those of leucine apparently because of runout into alternative metabolite pools, namely theR metabolites for isoleucine and the hydroxyacid for valine. The chronic accumulation of branched-chain 2-oxo acid(s) in our patients was associated with chronic dysmyelinating changes in CNS visible by imaging. Another patient with a thiamine-responsive variant of maple syrup urine disease had five acute crises incurring 29 days in hospital in a total of 6910 treatment days. However, she did not have chronic metabolic dyshomeostasis (her average plasma amino acid values were normal) and she had no evidence of dysmyelination. A relaxed treatment protocol for patients with maple syrup urine disease may benefit them in quality of life, but it apparently exacts a cost in metabolic control and CNS pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Brismar, J., Aqeel, A., Brismar, G., Coates, R.et al. Maple syrup urine disease: Findings on CT and MR scans of the brain in 10 infants.Am. J. Neuroradiol., 11 (1990) 1219–1228

    Google Scholar 

  • Chuang, D. T. Molecular studies of mammalian branched-chain ketoacid dehydrogenase complexes, domain structures, expression and inborn errors.Ann. N.Y. Acad. Sci. 573 (1989) 138–154

    Google Scholar 

  • Clow, C. L., Reade, T. M. and Scriver, C. R. Outcome of early and long-term management of classical maple syrup urine disease.Pediatrics 68 (1981) 856–862

    Google Scholar 

  • Danner, D. J. and Elsas, L. J. Disorders of branched-chain amino acid and ketoacid metabolism. In Scriver, C. R., Beaudet, A., Sly, W. and Valle, D. (eds.)The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 671–692

    Google Scholar 

  • Fisher, C. W., Chuang, J. L., Griffin, T. A., Lau, K. S., Cox, R. P. and Chuang, D. T. Molecular phenotypes in cultured Maple Syrup Urine Disease cells. Complete E1α cDNA sequence and mRNA and subunit contents of the human branched chainα-keto acid dehydrogenase complex.J. Biol. Chem. 264 (1989) 3448–3453

    Google Scholar 

  • Gregory, D. M., Sovetts, D., Clow, C. L. and Scriver, C. R. Plasma free amino acid values in normal children and adolescents.Metabolism 35 (1986) 967–969

    Google Scholar 

  • Harper, P. A., Dennis, J. A., Healy, P. J. and Brown, G. Maple syrup urine disease in calves. A clinical, pathological and biochemical study.Aust. Vet. J. 66 (1989) 44–49

    Google Scholar 

  • Hayes, A., Costa, T., Scriver, C. R. and Childs, B. The effect of Mendelian disease on human health. II: Response to treatment.Am. J. Med. Genet. 21 (1985) 243–255

    Google Scholar 

  • Haymond, M. W., Ben-Galim, E. and Strobel, K. Glucose and alanine metabolism in children with maple syrup urine disease.J. Clin. Invest. 62 (1978) 398–405

    Google Scholar 

  • Irnberger, V. T., Plochle, E. and Rittinger, O. Cranial computed tomography in maple syrup urine disease.ROFO 144 (1986) 413–417

    Google Scholar 

  • Kelts, D., Ney, D., Bay, C.et al. Studies on requirements for amino acids in infants with disorders of amino acid metabolism. I. Effect of alanine.Pediatr. Res. 19 (1985) 86–91

    Google Scholar 

  • Lancaster, G., Mamer, O. A. and Scriver, C. R. Branched-chain alpha keto acids isolated as oxime derivatives; relationship to the corresponding hydroxyacids and amino acids in maple syrup urine disease.Metabolism 23 (1974) 257–265

    Google Scholar 

  • Langenbeck, U. Pathobiochemical and pathophysiologic analysis of the MSUD phenotypes. In Abidi, S. A., Fekl, W., Langenbeck, U. and Schauder, P. (eds.)Branched Chain Amino and Keto Acids in Health of Disease, Karger, Basel, 1984 315–334

    Google Scholar 

  • Langenbeck, U., Wendel, U., Mench-Hoinowski, A., Kuschel, O., Becker, K.et al. Correlations between branched-chain amino acids and branched-chainα-keto acids in blood in maple syrup urine disease.Clin. Chim. Acta 88 (1978) 283–291

    Google Scholar 

  • Langenbeck, U., Wendel, U. and Luthe, H. Renal clearance of branched chain 2-oxo-acids in maple syrup urine disease.J. Clin. Chem. Biochem. 17 (1979) 176–177

    Google Scholar 

  • Mamer, O. A., Tjoa, S. S., Scriver, C. R. and Klassen, G. A. Demonstration of a new mammalian isoleucine catabolic pathway yielding an R series of metabolites.Biochem. J. 160 (1976) 417–426

    Google Scholar 

  • Mamer, O. A., Laschic, N. and Scriver, C. R. Stable isotope dilution assay for branched chainα-hydroxy andα-keto acids: Serum concentration for normal children.Biomed. Environ. Mass Spectrom. 13 (1986) 553–558

    Google Scholar 

  • Matthews, D. E., Schwartz, H. P., Yang, R. D., Young, V. R. and Bier, D. M. Relationship of plasma leucine andα-keto isocaproate during al-[1-13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichment.Metabolism 31 (1982) 1105–1112

    Google Scholar 

  • Pardridge, W. M. Blood brain transport of nutrients.Fed. Proc. 45 (1986a) 2047–2048

    Google Scholar 

  • Pardridge, W. M., Neutral amino acid transport at the human blood brain barrier.Fed. Proc. 45 (1986b) 2073–2078

    Google Scholar 

  • Pérez-Sala, D., Parrilla, R. and Ayuso, M. S. Key role ofl-alanine in the control of hepatic protein synthesis.Biochem. J. 241 (1987) 491–498

    Google Scholar 

  • Schadewaldt, P., Radeck, W., Hammen, H. W. and Wendel, U. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo-acids in cultured human skin fibroblasts.Pediatr. Res. 23 (1988) 40–44

    Google Scholar 

  • Schadewaldt, P., Hammen, H. W., Dalle-Feste, C. and Wendel, U. On the mechanism ofl-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.J. Inher. Metab. Dis. 13 (1990) 137–150

    Google Scholar 

  • Scriver, C. R., Mackenzie, S., Clow, C. L. and Delvin, E. Thiamine responsive maple syrup urine disease.Lancet 1 (1971) 310–312

    Google Scholar 

  • Scriver, C. R., Clow, C. L. and George, H. So-called thiamin-responsive maple syrup urine disease: a 15-year follow-up of the original patient.J. Pediatr. 107 (1985) 763–765

    Google Scholar 

  • Shigematsu, Y., Kikuchi, K., Momoi, T., Sudo, M., Kikawa, Y., Nosaka, K., Kuriyama, M., Hruki, S., Sanada, K., Hamano, N. and Suzuki, Y. Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in Maple Syrup Urine Disease.J. Inher. Metab. Dis. 6 (1983) 183–189

    Google Scholar 

  • Silberberg, D. H. Maple syrup urine disease metabolites studied in cerebellum cultures.J. Neurochem. 16 (1969) 1141–1146

    Google Scholar 

  • Snell, K. and Duff, D. A. Branched-chain amino acid metabolism and alanine formation in rat muscles in vitro.Biochem. J. 225 (1985) 737–743

    Google Scholar 

  • Snyderman, S. E., Goldstein, F., Sanswic, Q. and Norton, R. M. The relationship between the branched chain amino acids and their keto acids in maple syrup urine disease.Pediatr. Res. 18 (1984) 851–853

    Google Scholar 

  • Steele, R.D. Blood brain barrier transport of theα-keto analogues of amino acids.Fed. Proc. 45 (1986) 2060–2064

    Google Scholar 

  • Surtees, R. and Leonard, J. V. Acute metabolic encephalopathy: A review of causes. Mechanism and treatment.J. Inher. Metab. Dis. 12 (suppl. 1) (1989) 42–54

    Google Scholar 

  • Thompson, G. N., Bresson, J. L., Pacy, P. J., Bonnefont, J. P., Walter, J. H., Leonard, J. V., Saudubray, J. M. and Halliday, D. Protein and leucine metabolism in Maple Syrup Urine Disease.Am. J. Physiol. 258 (1990) E654-E660

    Google Scholar 

  • Tribble, D. and Shapira, R. Myelin proteins: Degradation in rat brain initiated by metabolites causative of maple syrup urine disease.Biochem. Biophys. Res. Commun. 114 (1983) 440

    Google Scholar 

  • Uziel, G., Savoiardo, M. and Nardocci, N. CT and MRI in maple syrup urine disease.Neurology 38 (1988) 486–488

    Google Scholar 

  • Wendel, U., Langenbeck, U. and Seakins, J. W. T. Interrelation between the metabolism ofl-isoleucine andl-allo-isoleucine in patients with Maple Syrup Urine Disease.Pediatr. Res. 25 (1989) 11–14

    Google Scholar 

  • Yeaman, S. J. The 2-oxo-acid dehydrogenase complex: recent advances.Biochem. J. 257 (1989) 625–632

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DeBelle Laboratory for Biochemical Genetics, McGill University-Montreal Children's Hospital Research Institute, 2300 Tupper Street, Canada

    E. Treacy, C. L. Clow, T. R. Reade, D. Chitayat & C. R. Scriver

  2. Biomedical/Mass Spectrometry Unit, McGill University, H3H 1P3, Montreal, Quebec, Canada

    O. A. Mamer

Authors
  1. E. Treacy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. L. Clow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. R. Reade
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Chitayat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. A. Mamer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. R. Scriver
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treacy, E., Clow, C.L., Reade, T.R. et al. Maple syrup urine disease: Interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15, 121–135 (1992). https://doi.org/10.1007/BF01800354

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01800354

Keywords

Search

Navigation